ConductScience.org, home

Paper24676741

Vancomycin: the tale of the vanquisher and the pyrrhic victory.

De Vriese AS and 1 other. Perit Dial Int, 2014. Cited by 11 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Vancomycin: the tale of the vanquisher and the pyrrhic victory. Papers, record 24676741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24676741

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vancomycin: the tale of the vanquisher and the pyrrhic victory.
PubMed
Journal
Perit Dial Int
PubMed
Year
2014
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2021-10-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1De Vriese ASAn S
2Vandecasteele SJStefaan J

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Methicillin-Resistant Staphylococcus aureusMajor topic
Staphylococcal InfectionsMajor topic
Staphylococcus aureusMajor topic
VancomycinMajor topic
Vancomycin ResistanceMajor topic
Humans
Risk Factors

Source PubMed

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,184,410Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.J Clin Microbiol2004https://conductscience.org/library/papers/15184410PubMed
220,628,102Peritoneal dialysis-related infections recommendations: 2010 update.Perit Dial Int2010https://conductscience.org/library/papers/20628102PubMed
319,635,961Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19635961PubMed
423,567,819The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.Infect Genet Evol2014https://conductscience.org/library/papers/23567819PubMed
522,302,374The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.Clin Infect Dis2012https://conductscience.org/library/papers/22302374PubMed
619,586,413Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.Clin Infect Dis2009https://conductscience.org/library/papers/19586413PubMed
723,165,462Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23165462PubMed
821,109,164VRSA-doomsday superbug or damp squib?Lancet Infect Dis2010https://conductscience.org/library/papers/21109164PubMed
921,540,106Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.Eur J Pharm Sci2011https://conductscience.org/library/papers/21540106PubMed
1022,284,995Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.Clin Ther2012https://conductscience.org/library/papers/22284995PubMed
119,249,217Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.J Antimicrob Chemother1997https://conductscience.org/library/papers/9249217PubMed
1215,462,252Vancomycin dosing in high flux hemodialysis: a limited-sampling algorithm.Am J Health Syst Pharm2004https://conductscience.org/library/papers/15462252PubMed
1317,369,615Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.Nephrol Dial Transplant2007https://conductscience.org/library/papers/17369615PubMed
142,354,591Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.Clin Pharmacokinet1990https://conductscience.org/library/papers/2354591PubMed
1514,506,006Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/14506006PubMed
1619,164,246Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.Perit Dial Int2009https://conductscience.org/library/papers/19164246PubMed
1715,561,842Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15561842PubMed
1824,047,554In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?J Antimicrob Chemother2014https://conductscience.org/library/papers/24047554PubMed
199,890,319
Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
J Am Soc Nephrol1999https://conductscience.org/library/papers/9890319PubMed
2019,590,063Staphylococcus aureus infections in hemodialysis: what a nephrologist should know.Clin J Am Soc Nephrol2009https://conductscience.org/library/papers/19590063PubMed

See all 53 references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
38,106,569The Association Between Serum Vancomycin Level and Clinical Outcome in Patients With Peritoneal Dialysis Associated Peritonitis.Kidney Int Rep2023https://conductscience.org/library/papers/38106569PubMed
32,065,053Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.Perit Dial Int2020https://conductscience.org/library/papers/32065053PubMed
28,836,582Influences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients.Acta Pharmacol Sin2018https://conductscience.org/library/papers/28836582PubMed
27,840,751Systemic Toxicity of Intraperitoneal Vancomycin.Case Rep Nephrol2016https://conductscience.org/library/papers/27840751PubMed
26,711,763Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26711763PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24676741

GET https://conductscience.org/api/papers/v1/24676741/references?page=2